Description
The abstract describes neuroinflammation as having dual effects - both exacerbating injury and facilitating recovery - but doesn’t explain what molecular or temporal factors determine this switch. Understanding this mechanism is critical for timing therapeutic interventions.
Gap type: unexplained_observation Source paper: The impact of cytokines in neuroinflammation-mediated stroke. (None, None, PMID:39004599)
Resolution criteria
Resolution requires: (1) Time-resolved single-cell transcriptomics of immune cells (microglia, infiltrating macrophages, T cells) from stroke mouse models at >=5 timepoints (1h to 30d), identifying >=2 distinct activation states with opposing effects on neuronal survival; (2) Cell-type specific ablation or inhibition (pharmacological or genetic) demonstrating that switching the balance from detrimental to protective inflammation reduces infarct volume by >=30% and improves functional outcome on >=2 behavioral tests; (3) Human stroke cohort validation (plasma or CSF cytokine panels + imaging) in n>=100 patients showing that the identified protective/detrimental axis predicts 90-day functional outcome. Acute inflammation measurement without temporal characterization of distinct activation states is insufficient.